Discover 870 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 870
Digoxin Medulloblastoma Study
for
Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Location: Birmingham AL, Nashville TN, Little Rock AR,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
Location: Birmingham AL, Atlanta GA, Nashville TN, Cincinnati OH,
Sponsor: SeaStar Medical
Sex: All
Age: 0 - 22
Code: NCT06517810
Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Birmingham AL, Atlanta GA, Memphis TN, Charlotte NC,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Location: Birmingham AL, Atlanta GA, Memphis TN, St Louis MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 18
Code: NCT05504291
Phase 2, Recruiting
Quality of End-of-Life Care for Children With Cancer
for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Birmingham AL, Pensacola FL, Atlanta GA, Little Rock AR,
Sponsor: Children's Oncology Group
Sex: All
Age: 18+
Code: NCT07412002
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Birmingham AL, Gainesville FL, St Louis MO,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT04485559
Phase 1, Recruiting
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
for
Acute Myeloid Leukemia Post Cytotoxic Therapy,
Location: Birmingham AL, Atlanta GA, Memphis TN, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT07012044
Phase 1, Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
for
Congenital Diaphragmatic Hernia
Location: Birmingham AL, Atlanta GA, Memphis TN, Nashville TN,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT05213676
Phase 4, Recruiting
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Birmingham AL, Nashville TN, New Orleans LA,
Sponsor: Children's Oncology Group
Sex: All
Age: 2 - 18
Code: NCT05711667
Phase 3, Recruiting
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
for
Type 2 Diabetes
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 12 - 18
Code: NCT06902077
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Birmingham AL, Atlanta GA, Memphis TN, St Louis MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase 1, Phase 2, Recruiting
I-DECIDE After Bronchiolitis Hospitalization
for
Bronchiolitis Acute
Location: Birmingham AL, Springfield MO, Cincinnati OH,
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 2
Code: NCT07243652
Recruiting
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
for
MPNST, NF1, Sarcoma
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT05253131
Phase 2, Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
for
Atypical Teratoid/Rhabdoid Tumor,
Location: Birmingham AL, Nashville TN, Little Rock AR,
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 0 - 26
Code: NCT06465199
Phase 1, Phase 2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Birmingham AL, Jackson MS, Mobile AL, Pensacola FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase 3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)